GGrantIndex
Sort

15,842 grants matching pancreatic cancer

CENTER FOR ALCOHOLIC LIVER AND PANCREATIC INJURY

$1,558,401
University Of Southern California · P50 · FY2001 · AA

Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer

$1,558,076
Anirban Maitra · University Of Tx Md Anderson Can Ctr · U54 · FY2022 · CA

Thoracic and Gastrointestinal Malignancies Branch Clinical Core

$1,555,914
Raffit Hassan · Division Of Basic Sciences - Nci · ZID · FY2023 · CA

UNMC Eppley Cancer Center Support Grant

$1,553,887
Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2008 · CA

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

$1,552,014
Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · DK

Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer

$1,547,949
William R Sellers · Dana-Farber Cancer Inst · P50 · FY2021 · CA

Tumor Microenvironment Crosstalk Drives Early Lesions in Pancreatic Cancer

$1,547,663
Anirban Maitra · New York University School Of Medicine · U54 · FY2025 · CA

Studies of Tumor-Penetrating Microparticles for Pancreatic Cancer

$1,546,525
Donald Lo · National Center For Advancing Translational Sciences · ZIA · FY2022 · TR

Defining RAS isoform- and mutation-specific roles in oncogenesis

$1,542,424
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2017 · CA

Gene expression and regulation in endocrine cancers

$1,541,934
Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Defining RAS isoform- and mutation-specific roles in oncogenesis

$1,539,964
Channing J Der · Univ Of North Carolina Chapel Hill · P01 · FY2018 · CA

Development and Preclinical Application of Pancreatic Adenocarcinoma Models

$1,539,864
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Preclinical drug development in pancreatic cancer

$1,539,190
Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

$1,538,195
Amato J. Giaccia · Stanford University · P01 · FY2014 · CA

Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms

$1,537,769
Randall Brand · University Of Pittsburgh At Pittsburgh · U01 · FY2017 · CA

Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease

$1,537,479
John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK

Studies of Rare Cancers

$1,537,322
Louise Brinton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Genome Characterization Unit

$1,533,382
Jeffrey M. Trent · University Of New Mexico Health Scis Ctr · U2C · FY2025 · CA

Technology Transfer

$1,533,071
Robert Angerer · National Institute Of Dental & Craniofacial Research · ZIK · FY2015 · DE

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)

$1,531,648
Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · DK

Clinical Studies of the Molecular Genetic Basis of Kidney Cancer

$1,530,871
William Marston Linehan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)

$1,530,169
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2011 · CA

Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies

$1,528,851
Ira Pastan · Basic Sciences · Z01 · FY2007 · CA

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

$1,528,477
Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA

Pancreatic Cancer Genetic Epidemiology Consortium

$1,528,414
Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2006 · CA